# GAL3ST1

## Overview
GAL3ST1 is a gene that encodes the enzyme galactose-3-O-sulfotransferase 1, a member of the sulfotransferase family. This enzyme is primarily involved in the sulfation of galactose residues in glycosphingolipids and glycoproteins, a process crucial for the synthesis of sulfatides. Sulfatides play significant roles in cellular functions such as cell-cell communication, signal transduction, and maintaining the integrity of the myelin sheath in the nervous system (Suchanski2018Sulfatide; HONKE2013Biosynthesis). The enzyme is active in the Golgi apparatus, where it catalyzes the conversion of galactosylceramide into sulfatide, impacting processes like myelination and spermatogenesis (Suchanski2018Sulfatide; Suzuki2010Expression). GAL3ST1's activity is essential for normal cellular and organismal functions, and its dysregulation has been implicated in various diseases, including clear cell renal cell carcinoma and sporadic Creutzfeldt-Jakob disease (Robinson2019A; Jones2020Genomewide).

## Structure
GAL3ST1 (galactose-3-O-sulfotransferase 1) is an enzyme that belongs to the sulfotransferase family, characterized by a conserved 5'-phosphosulfate (PAPS) binding domain. This domain is crucial for the enzyme's function, as it facilitates the transfer of sulfate groups to galactose residues in glycolipids and glycoproteins. The protein structure includes specific regions responsible for substrate binding and catalysis, which are essential for its enzymatic activity.

The enzyme may undergo post-translational modifications, such as glycosylation, which can influence its stability, localization, and function. These modifications are common in proteins involved in complex biochemical pathways, such as those involving glycolipids and glycoproteins.

GAL3ST1 can exist in multiple isoforms due to alternative splicing. These splice variants may result in proteins with differing functional properties, potentially affecting their enzymatic activity or interaction with other cellular components. The presence of these isoforms highlights the complexity of the regulation and function of GAL3ST1 in cellular processes. The specific structural details of primary, secondary, tertiary, and quaternary structures are not provided in the available context.

## Function
GAL3ST1 encodes the enzyme galactose-3-O-sulfotransferase 1, which plays a critical role in the sulfation of galactose residues in glycosphingolipids and glycoproteins. This enzyme is primarily active in the Golgi apparatus, where it catalyzes the transfer of sulfate groups to galactosylceramide (GalCer), converting it into sulfatide (Suchanski2018Sulfatide). Sulfatides are important for various cellular functions, including cell-cell communication and signal transduction, and are involved in maintaining cellular structures (Suchanski2018Sulfatide).

In the context of healthy human cells, GAL3ST1 is involved in the synthesis of sulfatides, which are crucial for myelination in the nervous system and play a role in the integrity of the myelin sheath (HONKE2013Biosynthesis). Sulfatides are also detected in renal tissue, where they may have regulatory roles, such as adaptation to metabolic acidosis (Porubsky2021The). The enzyme's activity is essential for the production of seminolipid, a glycolipid important for spermatogenesis, particularly during meiosis (Suzuki2010Expression). The absence of GAL3ST1 activity can lead to defects in these processes, highlighting its importance in normal cellular and organismal functions.

## Clinical Significance
Alterations in the GAL3ST1 gene have been implicated in several diseases, primarily through its role in sulfatide metabolism. In clear cell renal cell carcinoma (ccRCC), GAL3ST1 is significantly upregulated, contributing to immune evasion by enhancing tumor cell-platelet binding. This interaction protects cancer cells from natural killer cell-mediated destruction, facilitating metastasis and disease progression (Robinson2019A). The upregulation of GAL3ST1 in ccRCC is often linked to the loss of the VHL gene, leading to increased expression of hypoxia-inducible factors (HIFs) and subsequent upregulation of GAL3ST1 (Robinson2019A).

In the context of neurological disorders, GAL3ST1 has been associated with sporadic Creutzfeldt-Jakob disease (sCJD), a rare and fatal neurodegenerative disorder. Genome-wide association studies have identified risk variants in GAL3ST1 that are linked to an increased risk of sCJD, suggesting that alterations in this gene may contribute to the disease's pathogenesis (Jones2020Genomewide). These findings highlight the clinical significance of GAL3ST1 in both cancer and neurodegenerative diseases, underscoring its potential as a therapeutic target.


## References


[1. (Suzuki2010Expression) Teruhiko Suzuki, Natsuki Kosaka-Suzuki, Svetlana Pack, Dong-Mi Shin, Jeongheon Yoon, Ziedulla Abdullaev, Elena Pugacheva, Herbert C. Morse, Dmitri Loukinov, and Victor Lobanenkov. Expression of a testis-specific form of gal3st1 (cst), a gene essential for spermatogenesis, is regulated by the ctcf paralogous gene boris. Molecular and Cellular Biology, 30(10):2473–2484, May 2010. URL: http://dx.doi.org/10.1128/mcb.01093-09, doi:10.1128/mcb.01093-09. This article has 64 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.01093-09)

[2. (HONKE2013Biosynthesis) Koichi HONKE. Biosynthesis and biological function of sulfoglycolipids. Proceedings of the Japan Academy, Series B, 89(4):129–138, 2013. URL: http://dx.doi.org/10.2183/pjab.89.129, doi:10.2183/pjab.89.129. This article has 48 citations.](https://doi.org/10.2183/pjab.89.129)

3. (Jones2020Genomewide) Genome-wide association study identifies risk variants for sporadic Creutzfeldt-Jakob disease in STX6 and GAL3ST1. This article has 0 citations.

[4. (Porubsky2021The) Stefan Porubsky, Malin Nientiedt, Maximilian C. Kriegmair, Jörn-Helge Heinrich Siemoneit, Roger Sandhoff, Richard Jennemann, Hendrik Borgmann, Timo Gaiser, Cleo-Aron Weis, Philipp Erben, Thomas Hielscher, and Zoran V. Popovic. The prognostic value of galactosylceramide-sulfotransferase (gal3st1) in human renal cell carcinoma. Scientific Reports, May 2021. URL: http://dx.doi.org/10.1038/s41598-021-90381-6, doi:10.1038/s41598-021-90381-6. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-021-90381-6)

[5. (Robinson2019A) Claire M. Robinson, Betty P.K. Poon, Yoshihito Kano, Fred G. Pluthero, Walter H.A. Kahr, and Michael Ohh. A hypoxia-inducible hif1–gal3st1-sulfatide axis enhances ccrcc immune evasion via increased tumor cell–platelet binding. Molecular Cancer Research, 17(11):2306–2314, November 2019. URL: http://dx.doi.org/10.1158/1541-7786.mcr-19-0461, doi:10.1158/1541-7786.mcr-19-0461. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1158/1541-7786.mcr-19-0461)

[6. (Suchanski2018Sulfatide) Jaroslaw Suchanski, Jedrzej Grzegrzolka, Tomasz Owczarek, Pawel Pasikowski, Aleksandra Piotrowska, Bartlomiej Kocbach, Aleksandra Nowak, Piotr Dziegiel, Andrzej Wojnar, and Maciej Ugorski. Sulfatide decreases the resistance to stress-induced apoptosis and increases p-selectin-mediated adhesion: a two-edged sword in breast cancer progression. Breast Cancer Research, November 2018. URL: http://dx.doi.org/10.1186/s13058-018-1058-z, doi:10.1186/s13058-018-1058-z. This article has 26 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1186/s13058-018-1058-z)